Imlifidase Recruiting Phase 2 Trials for Guillain-Barré Syndrome (GBS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03943589A Study of Imlifidase in Patients With Guillain-Barré Syndrome